Metraipolis › archive › dc_a8b59e803e4d

Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study — Europe PMC PMID:40820125

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40820125
DOI
10.1186/s12879-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-10T13:49:59.658Z
SHA-256 of the archived text
5c296158af640978a759918dbf5666a2b981d1ef72293724022e2a87835d2a97
Stable URL of this page
https://metraipolis.com/documento/dc_a8b59e803e4d

How to cite

Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study — Europe PMC PMID:40820125 — Europe PMC (en), https://europepmc.org/article/MED/40820125 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a8b59e803e4d (Metraipolis archive dc_a8b59e803e4d, sha256 5c296158af640978a759918dbf5666a2b981d1ef72293724022e2a87835d2a97)
BibTeX
@misc{dca8b59e803e4d,
  title = {Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study — Europe PMC PMID:40820125},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40820125},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a8b59e803e4d; sha256 5c296158af640978a759918dbf5666a2b981d1ef72293724022e2a87835d2a97},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40820125. Agents can read the archived copy with the MCP tool read_document.